Kirk A. Christoffersen
Corporate Officer/Principal chez FIBROGEN, INC.
Postes actifs de Kirk A. Christoffersen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FIBROGEN, INC. | Corporate Officer/Principal | 01/11/2020 | - |
Historique de carrière de Kirk A. Christoffersen
Anciens postes connus de Kirk A. Christoffersen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| COMPUGEN LTD. | Corporate Officer/Principal | 05/12/2016 | 08/01/2020 |
| GLOBEIMMUNE, INC. | Corporate Officer/Principal | 01/11/2004 | 03/08/2015 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2002 | 01/01/2004 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/1998 | 01/01/2002 |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Corporate Officer/Principal | - | - |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - | - |
Formation de Kirk A. Christoffersen
| University of Michigan | Undergraduate Degree |
| Daniels College of Business | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 9 |
| Israël | 2 |
Opérationnelle
| Corporate Officer/Principal | 7 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 6 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| GLOBEIMMUNE, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| COMPUGEN LTD. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Commercial Services |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
- Bourse
- Insiders
- Kirk A. Christoffersen
- Expérience
